Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|10|2|208-240

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.10, Iss.2, 2013-04, pp. : 208-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Delivery Systems with Modified Release for Systemic and Biophase Bioavailability

By  

Current Clinical Pharmacology, Vol. 7, Iss. 4, 2012-11 ,pp. : 282-317

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticulate Drug Delivery Systems

By Senior Judy  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 1, 2008-01 ,pp. : 116-116

Informa Healthcare

Access to resources Recommend Favorite

Lipid-Based Nanoparticulate Systems for the Delivery of Anti-Cancer Drug Cocktails: Implications on Pharmacokinetics and Drug Toxicities

By  

Current Drug Metabolism, Vol. 10, Iss. 8, 2009-10 ,pp. : 861-874

Bentham Science Publishers

Access to resources Recommend Favorite

Potential of Nanoparticulate Drug Delivery Systems by Intranasal Administration

By  

Current Pharmaceutical Design, Vol. 16, Iss. 14, 2010-05 ,pp. : 1644-1653

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in Nanoparticulate Systems for Peptide, Proteins and Nucleic Acid Drug Delivery

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1823-1839

Bentham Science Publishers

Access to resources Recommend Favorite